Regulation of Medical Devices: Tanzania experience Fimbo, A. M Tanzania Food and Drugs Authority.

Slides:



Advertisements
Similar presentations
REGULATING AFLATOXIN CONTAMINATION IN FOOD PRODUCTS BY RAYMOND N. WIGENGE Director of Food Safety Tanzania Food and Drugs Authority.
Advertisements

Armand Racine Consultant Chemicals Branch
Development Cycle of Medical Devices: A Path of Opportunities for Information Professionals Donna Gay Pharma & Health Tech Div, SLA 2007 Spring Meeting.
And the provisions of….. the Medical Devices Regulations Medical Devices Agency.
Sorenson Medical, West Jordan, Utah USA Medical Device Development Robert Hitchcock, Ph.D. Director of Engineering & Technology Development Sorenson Medical,
Regulatory Pathway for Platform Technologies
The regulation of medical devices in Australia. Overview Comparing medicines and medical devices What is a medical device? Statistics on patients requiring.
SALDA In Vitro Diagnostics in South Africa Welcome 5 November 2014 Portfolio Committee Bill
510k Submission Overview Myraqa, Inc. August 22, 2012.
University of Medicine and Dentistry of New Jersey John L. Ricci, Ph.D., Department of Orthopaedics History and Scope of Biomaterials J. L. Ricci, Ph.D.
FEDERAL REGULATIONS OF MEDICATIONS Food, Drug and Cosmetic Act Protect consumers from adulterated and misbranded foods, drugs, cosmetics, or devices.
Special Topics in IND Regulation
Medical Devices Approval Process
Rajiv Nath, President, AISNMA Forum Coordinator,AIMED.
The FDA Landscape AdvaMed September 2008 Judith K. Meritz
+ Medical Devices Approval Process. + Objectives Define a medical device Be familiar with the classification system for medical devices Understand the.
1 FDA Thailand By HIV Module/Marketing Group Mr. Manaswee Arayasiri.
Weaving regulations into sound value analysis processes Barbara Strain, MA, SM(ASCP) Director Value Management University of Virginia Health System.
Classification of HLA Devices FDA Introduction & Background Sheryl A. Kochman CBER/OBRR/DBA.
Product Definition Chapter 4. What is a Medical Device? FDA: “an instrument, apparatus, implement, machine, contrivance, implant, in vitro reagent,
Presented by: George Howe Executive Vice President Business Development & OEM Accounts.
Device Research Presented by Marian Serge, R.N.. Goals Identify devices Recognize difference between significant risk (SR) and non- significant risk (NSR)
Introduce on Imported Foods System in Korea - Under The Food Sanitation Act - Korea Food and Drug Administration.
Prof. Moustafa M. Mohamed Vice dean Faculty of Allied Medical Science Pharos University in Alexandria Development and Regulation of Medical Products (MEDR-101)
The Medical Device Pathway as a Legal Onramp for Futuristic Persons THE FUTURE T HE M EDICAL D EVICE P ATHWAY AS A L EGAL.
THE HIGHLIGHTS OF DRUG REGULATION IN KENYA. Presentation by: Dr. Joseph K. Yano B.Pharm (Nbi) L.L.B (Moi) Legal Officer Pharmacy and Poisons Board Ministry.
1 Importation of Medical Devices FDA Chicago District O’Hare Import Resident Post August 26, 2010 Import Entry Review Team Tamara M. Qtami, CSO.
Health and Consumers Directorate-General (DG SANCO) Howard Batho, Head of import and OIE sector Unit D1, Animal Health and Standing Committees.
CE MARKING OF IVDDs - the NIBSC perspective Morag Ferguson Division of Virology.
Medical Devices IRB Determination IRB Member Continuing Education.
Compliance with FDA Regulations: Collecting, Transmitting and Managing Clinical Information Dan C Pettus Senior Vice President iMetrikus, Inc.
1 CONSENSUS STANDARDS OIVD WORKSHOP April 22-23, 2003 Rockville MD Ginette Y. Michaud, M.D. OIVD.
SALDA Presentation to the Honourable Portfolio Committee on Health National Health Act Amendment Bill B March 2012.
NRA in BTSs of the EMR Dr. Nabila E. Metwalli Regional Advisor / Blood Safety WHO / EMRO Cairo, Egypt and Dr. Abdel Aziz Saleh WHO / EMRO Advisor.
Towards ISO Standards for AD syringes: Update from WHO Gerald Verollet World Health Organization 3rd SIGN Meeting - New Delhi.
OVERVIEW OF THE ROLES OF VARIOUS INSTITUTIONS AND REGULATORY FRAMEWORK FOR AFLATOXIN CONTROL IN TANZANIA RAYMOND N. WIGENGE DIRECTOR OF FOOD SAFETY TFDA.
This class cannot be shared or copied without the written permission of PracticeWorks Systems, LLC.
Center for Drug Evaluation and Research (CDER) Tanya Eberle Kamal Diar David Clements.
UPCOMING CHANGES TO IN-VITRO DIAGNOSTICS (IVDs) AND LABORATORY DEVELOPED TESTS (LDTs) REGULATIONS Moj Eram, PhD November 5, 2015.
REGULATION OF MEDICAL DEVICES INNOVATION TUĞÇE YAŞAR
PHARMACOVIGILANCE PLAN FOR TANZANIA PREPARED BY EMMA & MARY 10 TH SEPTEMBER 2004.
Food, Drug and Cosmetic Act Jose Simon P. Simangan Jr. SEMFILA EA2.
3rd WHO Prequalification Stakeholders Meeting :Diagnostics 3rd Stakeholders Meeting on Prequalification Geneva, 4th February 2008 Update on Prequalification.
FAS Training 2016 SMR 4 Food and Feed Hygiene Carrick on Shannon, Charleville, Kilkenny Integrated Controls Division 1.
Strategic Objective 4 To promote the exchange of experiences and regulatory knowledge between NRAs inside and outside PANDRH“ Lessons learned from international.
Leveraging the prequalification process for national regulatory decision making Fimbo, A. M Tanzania Food and Drugs Authority.
1 CHALLENGES IN REGULATING QUALITY AND RATIONAL USE OF ANTIBIOTICS ALLIANCE FOR THE PRUDENT USE OF ANTIBIOTICS: INAGURAL MEETING COURTYARD.
1 CHALLENGES IN REGULATION OF TRADITIONAL AND ALTERNATIVE MEDICINES 24 th March, 2010 MOHSW Conference Room Registration of Herbal Drugs.
Steps for the Integration of Traditional Medicine in the National Health Care Delivery System 18 TH ICASA Special Session on Traditional Medicine 1 st.
M O N T E N E G R O Negotiating Team for the Accession of Montenegro to the European Union Working Group for Chapter 1 – Free movement of goods Bilateral.
Section I General principle of Pharmacology. Where can you get information about general principle of Pharmacology?  Text books:  Katzung, Basic and.
PD233: Design of Biomedical Devices and Systems (Lecture 2) Dr. Manish Arora CPDM, IISc Course Website:
ROLES AND RESPONSIBILITIES OF TFDA ON ADDO PROGRAM
National Food Control Systems
Executive Director, Registrar Corp
GCP AND MEDICAL DEVICES
EAST AFRICAN COMMUNITY MEDICINES REGULATORY HARMONIZATION (EAC-MRH) PROJECT PROGRESS NAIROB I - KENYA By: EAC - Secretariat.
Irena Prat and Josée Hansen World Health Organization
Overview of regulatory and compliance in software development for medical devices
Get Ready for FDA Oversight of Laboratory Developed Tests Presenter:
EU Reference Centres for Animal Welfare
MEDICAL DEVICES CONTROL SYSTEM IN INDONESIA
Supporting Implementation of the EDL
Dr Manisha Shridhar Regional Advisor WHO-SEARO
Er. Ajai Basil Consultant, Healthcare Technologies (Medical devices)
Regulation of medical devices and diagnostics in India
Regulation in South-East Asia Joint Drugs Controller (India)
Regulatory framework of Medical devices
A FRIENDLY REMINDER ON OTC DRUGS. DRUG REGULATIONS IN THE PHILIPPINES.
THE HIGHLIGHTS OF DRUG REGULATION IN KENYA
Presentation transcript:

Regulation of Medical Devices: Tanzania experience Fimbo, A. M Tanzania Food and Drugs Authority

2 Outline ► Background ► Key milestones in regulation of medical devices ► Implementation phases of regulation of medical devices ► Regulatory processes ► Evaluation and registration ► Control of importation ► GMP/QMS inspection ► Post marketing surveillance ► Lessons learnt & challenges ► Conclusion

Background ► TFDA - Executive Agency under the Ministry of Health and Social Welfare ► Established under the Tanzania Food, Drugs and Cosmetics Act No.1, 2003 ► TFDA Mission - Protect and promote public health by ensuring quality, safety and effectiveness of food, drugs, cosmetics and medical devices. ► Mandated under Section 5(1)(a) of the Tanzania Food, Drugs and Cosmetics Act, 2003 to regulate all matters relating to quality, safety and performance of medical devices including importation, manufacture, labeling, storage, promotion, sell and distribution of medical devices in the country.

Background……… ► Definition of medical device - An instrument, apparatus, implement, medical, equipment, machine, contrivance, implant, in vitro reagent, or other similar or related article, including any component, part or accessory, which is: ► recognized in the Official National Formulary, or Pharmacopoeia or any supplement to them; ► intended for use in the diagnosis of disease or other conditions, or in the cure, mitigation, treatment or prevention of disease, in man or animals or; ► intended to affect the structure or any function of the body of man or animals and which does not achieve any of its principal intended purposes through chemical action within the body of man or animals and which is not dependent upon being metabolized for the achievement of any of its principle intended purposes. ► (Section 3 of TFDA Act, 2003)

5 Key Milestones ► 1999: Control of importation started under Pharmacy Board ► 2003: TFDA was established ► 2008: Department of Medical Devices Assessment and Enforcement created ► : Notification of all devices on the market started (3,500 devices notified) ► 2010: 1 st phase of registration started and still on going ► Up to 2012: 218 applications received (79 devices registered)

Implementation phases of regulation of medical devices 6 Phase IPhase IIPhase III Activities Control of importation of medical devices - Ongoing Development of guidelines: Registration of Devices Licensing of Premises Good Distribution Practices Post Marketing Surveillance Completed Activities Registration of medical devices – started and still ongoing Licensing of premises dealing with medical devices - Ongoing Advertisement and promotion control – Not yet started Activities Prohibition against unlicensed premises dealing with medical devices – Enforcement ongoing Prohibition against supply of unregistered medical devices – Partial enforcement has started for devices which have been registered

Evaluation and registration of devices (Done based on risk classification) ClassRisk LevelExamples ALow riskSurgical retractors/ tongue depressors BLow – moderate riskHypodermic Needles/ suction equipment CModerate – high riskLung ventilator/bone fixation plate DHigh riskHeart valves/ implantable defibrillator

Evaluation & registration of devices ► Some class A devices are exempted from registration ► All devices in class B, C and D require registration ► The evaluation process for registration of devices is done in two stages: ► Screening ► Evaluation

Evaluation & registration of devices ► All class B, C and D devices are evaluated after the screening stage before registration ► The evaluation process for Class A non exempted devices ends at screening stage

Evaluation & registration of devices ► Guidelines on Submission of Documentation for Registration of Medical Devices has been developed for applicants to follow through when compiling data for registration ► The registration guidance document has many elements of the Summary Technical Documentation (STED)

List of devices under 1 st phase of registration 1. Syringes 2. Surgical sutures 3. Examination & surgical gloves 4. Scalp vein set 5. Intravenous cannulae 6. Catheters and tubes 7. Condoms 8. Needles 9. Administration Sets (blood lancets and I.V giving sets) 10.Blood collection bags 11.Surgical dressings 12. Internal prosthetic replacements 13.Orthopaedic implants 14.Bone cements 15.Drug eluting stents and; 16.Intraocular lenses 11

Control of importation ► Receipt of application form and proforma invoice ► Devices must either be notified or registered (phase 1 devices) ► For unregistered devices Tanzania Bureau of Standards (TBS) CoA is used as a basis for approval

GMP/QMS Inspection ► Not done at the moment ► Considered during evaluation whereby manufacturers are required to comply with ISO 13485:2003 and ISO 9001:2008 ► Certificate needs to be submitted

Post Marketing Surveillance ► Guidelines on Post Marketing Surveillance of Medical Devices including In-vitro Diagnostic Devices have been developed ► PMS programme manual has also been developed ► Phase 1 plan is to collect samples of syringes, condoms and gloves from the market and test them at TFDA Lab

WHO Pilot Project on strengthening regulatory capacity of diagnostics and PMS ► Tanzania is one of 5 countries implementing the WHO pilot project ► Objectives ► Building and/or strengthening of national regulatory capacity and PMS of diagnostics ► Strengthening procurement and supply chain management of priority diagnostics ► Building and/or strengthening of National Health Laboratory Quality Assurance and Training Centre to carry on testing of diagnostic batches

WHO Pilot Project…. ► Through this project samples of IVD’s to include HIV test kits and malaria rapid diagnostic test kits (RDTs) will be collected from the market and tested ► This will ensure availability of quality diagnostics in Tanzania

Lessons learnt and Challenges ► Devices are many in numbers and of varying technologies and complexities ► Inadequate number of medical device laboratories within the region for performance evaluation is a challenge ► A stepwise approach in regulation of devices should be considered since devices vary in technologies and design ► Skilled regulatory experts in this area are few hence it is a rate limiting factor for regulation ► Few countries regulate devices in Africa ► Stakeholders involvement is crucial in setting up regulatory system for medical devices

Conclusion ► Capacity building for regulation of medical devices in developing countries should be prioritized by WHO. ► Countries should start to consider setting up policies, laws and regulations for control of devices to ensure that they are safe, of good quality and perform to standards. This will help protect and promote public health. ► A platform for exchange of regulatory information on medical devices should be established to enable better exchange of information e.g. biannual international conferences.